Tandem Diabetes Care (TNDM) PT Raised to $22 at Stifel Following Q4 Revenue Beat
Tweet Send to a Friend
(Updated - February 20, 2026 10:14 AM EST)
Stifel analyst Jonathan Block raised the price target on Tandem Diabetes ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Jonathan Block raised the price target on Tandem Diabetes ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
